Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.

Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M.

Gastroenterology. 2014 Jun;146(7):1649-58. doi: 10.1053/j.gastro.2014.02.031. Epub 2014 Feb 25.

PMID:
24583059
[PubMed - indexed for MEDLINE]
2.

Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.

Siegel M, Garber ME, Spencer AG, Botwick W, Kumar P, Williams RN, Kozuka K, Shreeniwas R, Pratha V, Adelman DC.

Dig Dis Sci. 2012 Feb;57(2):440-50. doi: 10.1007/s10620-011-1906-5. Epub 2011 Sep 23.

PMID:
21948339
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk